Rankings
▼
Calendar
MNKD Q3 2017 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$841M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-98.7% YoY
Gross Profit
-$3M
-123.9% margin
Operating Income
-$28M
-1379.3% margin
Net Income
-$33M
-1609.7% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
-5.5%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$56M
Total Liabilities
$307M
Stockholders' Equity
-$251M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$162M
-98.7%
Gross Profit
-$3M
$135M
-101.9%
Operating Income
-$28M
$118M
-123.8%
Net Income
-$33M
$127M
-126.0%
Revenue Segments
Product
$900,000
100%
← FY 2017
All Quarters
Q4 2017 →